openPR Logo
Press release

Retinoblastoma Treatment Market Growth, Size, Share and Forecast 2020-2026

07-07-2020 11:36 AM CET | Health & Medicine

Press release from: Orion Market Research

Retinoblastoma Treatment Market Growth, Size, Share

The global retinoblastoma treatment market is anticipated to grow at a significant CAGR during the forecast period. Retinoblastoma is a type of cancer that affects the retina. Although retinoblastoma is a rare disorder, it is still found to be very common eye cancer in children of age below 5 years. According to the National Organization for Rare Disease Disorder (NORD), retinoblastoma is considered to be a leading cause of blindness in children and accounts for almost 3% of all childhood malignancies. Hence, the high prevalence of retinoblastoma will significantly drive the retinoblastoma treatment market.

A full report of Global Retinoblastoma Treatment Market is available at: https://www.omrglobal.com/industry-reports/retinoblastoma-treatment-market

The treatment of retinoblastoma includes various drug delivery and chemotherapy techniques which can provide some timely benefits. Surgery in retinoblastoma is expected to be a permanent treatment option as it removes the tumor completely from the retina. Therefore, the adoption of surgery will rise considering its permanent benefits, in turn driving the retinoblastoma treatment industry considerably during the forecast period.

Additionally, the use of chemotherapy in the retinoblastoma treatment market is also anticipated to rise in recent times owing to the presence of various chemotherapy approaches. For instance, intraarterial chemotherapy is one such chemotherapy approach that involves a surgical procedure. However, the side effects associated with chemotherapy such as transfusions, infected ports, fevers, neutropenia, and many more will restrict the growth of chemotherapy in the retinoblastoma treatment market.

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/retinoblastoma-treatment-market

Moreover, various other side-effects were also observed in the treatment of retinoblastoma treatment including vision loss in the long-term that eventually lead to the removal of the eye. This is anticipated to significantly lower the growth rate of the retinoblastoma treatment market during the forecast period. Therefore, new therapeutic strategies are being considered for the retinoblastoma treatment that is more efficient and has less associated side effects which will drive the market growth.

Besides the side effects of retinoblastoma treatment, the survival rate of patients with this condition is also considerably high that is up to 95% if it was not spread to any other body part. Hence, the high survival rate will drive the adoption of treatment, in turn, fuelling the growth of the retinoblastoma treatment market during the forecast period.

Global Retinoblastoma Treatment Market- Segmentation

By Treatment Type

• Surgery
• Radiation therapy
• Laser Therapy (Photocoagulation)
• Cryotherapy
• Thermotherapy
• Chemotherapy

By Type of Retinoblastoma

• Non-hereditary Retinoblastoma
• Hereditary Retinoblastoma

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/retinoblastoma-treatment-market

Global Retinoblastoma Treatment Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• AbbVie Inc.
• Accuray Incorporated
• Baxter International Inc.
• Bristol-Myers Squibb Co.
• Cadila Pharmaceuticals Ltd.
• CryoConcepts LP.
• GlaxoSmithKline plc
• Hikma Pharmaceuticals PLC
• Johnson & Johnson Services, Inc.
• Merck & Co. Inc.
• Novartis International AG
• Pfizer Inc.
• Sanofi S.A.
• Teva Pharmaceutical Industries Ltd.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinoblastoma Treatment Market Growth, Size, Share and Forecast 2020-2026 here

News-ID: 2085919 • Views: 399

More Releases from Orion Market Research

Global Anything as a Service Market Top Leading Players with Strategies and Fore …
The global Anything as a Service (XaaS) market is anticipated to grow at a considerable CAGR of 24.1% during the forecast period (2022-2028). XaaS is a general term used collectively for cloud-based remote services, including storage as a service, security as a service, network as a service, and many others. The major factor attributing to the growth of the global XaaS market includes the increasing application of the XaaS platform
Global Power Wheelchair Tires Market Top Leading Players with Strategies and For …
The global power wheelchair tires market is anticipated to grow at a CAGR of 6.2% during the forecast period (2022-2028). Power wheelchairs are useful for those unable to use a manual wheelchair or who may need to use a wheelchair for distances or over terrain which would be fatiguing in a manual wheelchair. Every electric wheelchair has a base, which is equipped with four or more wheels. Power wheelchair tires have
Global Self-Drive Car Rentals Market Top Leading Players with Strategies and For …
The global self-drive car rentals market is anticipated to grow at a considerable CAGR of 6.7% during the forecast period (2022-2028). Self-drive car rentals are the services that allow an individual to rent a car to drive and use it for several purposes including local usage, travel and exploration to different places, among others. The major factor attributing to the growth of the global self-drive car rentals market includes the
Disposable Surgical Gowns Market Trends, Business Overview, Industry Growth and …
The global disposable surgical gowns market is anticipated to grow at a CAGR of 6.5% during the forecast period (2022-2028). The major factor expected to drive the market growth is the increasing number of surgeries, growing instances of Hospital-Acquired Infections (HAIs) (HAIs are nosocomial infections that are more frequent in people undergoing long-term care, most notably surgical procedures.), technological advancements, increasing cases of hospitalizations due to COVID-19 as well as

All 5 Releases


More Releases for Retinoblastoma

Retinoblastoma Treatment Market Trends, Research Report, Growth, Opportunities, …
The global retinoblastoma treatment market is anticipated to grow at a significant CAGR during the forecast period. Retinoblastoma is a type of cancer that affects the retina. Although retinoblastoma is a rare disorder, it is still found to be very common eye cancer in children of age below 5 years. According to the National Organization for Rare Disease Disorder (NORD), retinoblastoma is considered to be a leading cause of blindness
Retinoblastoma Treatment Market Size, Analytical Overview, Growth factors, Deman …
"The Latest Research Report Retinoblastoma Treatment Market: Global Industry Analysis and Opportunity Assessment 2017-2027 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. – MarketResearchReports.biz” Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. It is
Retinoblastoma Treatment Market has been segmented on the basis of disease type, …
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. It is the most common type of eye cancer in children. During the early stages of development, the eyes have cells called retinoblasts that divide into new cells and fill the retina.
Retinoblastoma Treatment Market size and Key Trends in terms of volume and value …
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. It is the most common type of eye cancer in children. During the early stages of development, the eyes have cells called retinoblasts that divide into new cells and fill the retina.
Retinoblastoma Drugs Market: Moving Towards a Brighter Future
Worldwide Market Reports added Latest Research Report titled “Global Retinoblastoma Drugs Market Research Report 2018” to its Large Report database. Retinoblastoma Drugs Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The
Retinoblastoma Treatment Market : Dynamics, Segments, Size and Demand, 2017 – …
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). Retinoblastoma is a cancer that starts in the retina, the very back part of the eye. It is the most common type of eye cancer in children. During the early stages of development, the eyes have cells called retinoblasts that divide into new cells and fill the retina.